ADAMTS13检测在血栓性微血管病和血栓形成诊断与管理中的作用
综述阐述ADAMTS13的生物学及其检测方法,讨论其在血栓性血小板减少性紫癜急性期与随访中的价值,并汇总ADAMTS13在其他血栓性微血管病、缺血性卒中和冠状动脉疾病中的最新证据,供临床评估微血管病性溶血性贫血伴血小板减少及TTP随访决策参考。
要点
- ADAMTS13活性严重缺乏可触发血栓性血小板减少性紫癜(TTP)急性发作。
- ADAMTS13通过裂解超大分子血管性血友病因子(VWF)多聚体,在活性严重缺乏或仅中度降低时均可表现促血栓和促炎特性。
- ADAMTS13检测有助于TTP急性期评估和随访决策,并与其他血栓性微血管病、卒中和心血管病的评估相关。
核心结论
- ADAMTS13活性严重缺乏可触发TTP急性发作,检测其功能对TTP急性期和随访评估有用。
- ADAMTS13通过作用于VWF,在活性严重缺乏或仅中度降低时均可具有促血栓和促炎特性。
- ADAMTS13在其他血栓性微血管病、缺血性卒中和冠状动脉疾病中的作用已有最新证据。
研究设计与样本
- 综述,未报告检索范围与样本量。
主要发现
- ADAMTS13是一种金属蛋白酶,负责裂解超大分子VWF多聚体。
- ADAMTS13活性严重缺乏可触发TTP急性发作。
- ADAMTS13活性严重缺乏或仅中度降低时均可通过作用于VWF表现促血栓和促炎特性。
临床怎么用
- 文中信息有助于临床医生评估表现为微血管病性溶血性贫血和血小板减少的患者。
- 文中信息有助于临床医生对TTP患者随访作出临床决策。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
ADAMTS13 (a disintegrin and metalloproteinase with thrombospondin type 1 motif, 13) is a metalloprotease responsible for cleavage of ultra-large von Willebrand factor (VWF) multimers. Severely deficient activity of the protease can trigger an acute episode of thrombotic thrombocytopenic purpura (TTP). Our understanding of the pathophysiology of TTP has allowed us to grasp the important role of ADAMTS13 in other thrombotic microangiopathies (TMAs) and thrombotic disorders, such as ischemic stroke and coronary artery disease. Through its action on VWF, ADAMTS13 can have prothrombotic and proinflammatory properties, not only when its activity is severely deficient, but also when it is only moderately low. Here, we will discuss the biology of ADAMTS13 and the different assays developed to evaluate its function in the context of TTP, in the acute setting and during follow-up. We will also discuss the latest evidence regarding the role of ADAMTS13 in other TMAs, stroke, and cardiovascular disease. This information will be useful for clinicians not only when evaluating patients who present with microangiopathic hemolytic anemia and thrombocytopenia, but also when making clinical decisions regarding the follow-up of patients with TTP.
引用
- Masias C, Cataland SR. The role of ADAMTS13 testing in the diagnosis and management of thrombotic microangiopathies and thrombosis. Blood. 2018. PMID: 30006329. doi:10.1182/blood-2018-02-791533
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。